Biotech to test new therapy for stroke
By Kris B. Mamula, Pittsburgh Post-Gazette A 3-year-old Sewickley, Pennsylvania, biotech firm is partnering with a Boston hospital to test a new drug combination, which has the promise of helping …
By Kris B. Mamula, Pittsburgh Post-Gazette A 3-year-old Sewickley, Pennsylvania, biotech firm is partnering with a Boston hospital to test a new drug combination, which has the promise of helping …
Alphabet incoming CFO Anat Ashkenazi, who spent 23 years at Eli Lilly Eli Lilly Alphabet’s outgoing finance chief, Ruth Porat, spent the past year and a half trying to help …
By Brenda Goodman | CNN After decades of false starts, researchers say they are finally making progress on a long-acting and reversible birth control option for men. The experimental product …
Rick Doblin first dreamed of the therapeutic potential of the psychedelic drug MDMA in a hippie house in downtown Santa Cruz, in an era when fears of bad trips and …
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. Matthew Childs | Reuters LONDON — Shares of British pharmaceuticals giant GSK plunged 9% …
The FDA has approved Moderna’s RSV vaccine for older adults. Courtesy: Moderna The Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory syncytial virus for adults ages 60 …
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market …
GLP-1 Supply Tracker from Ro. Courtesy: Ro Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called …
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. Wall Street was bouncing …
Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are calling a “massive opportunity.” It’s called …